Literature DB >> 26435476

"Retronychia--clinical and pathophysiological aspects".

F Ventura1, O Correia1, A F Duarte1, A M Barros1, E Haneke1,2.   

Abstract

Retronychia represents proximal ingrowth of the nail that occurs when the nail embeds backwards into the proximal nail fold. It is suspected when there is a persistent paronychia, particularly in the setting of trauma. Important clinical criteria for diagnosis are inflammation of the proximal nail fold, granulation tissue emerging from under the nail fold, thickening of the proximal portion of the nail plate and interruption of nail growth. The condition is rarely diagnosed and often misinterpreted, and is therefore unnecessarily treated with systemic antibiotics and antifungals. Avulsion of the nail confirms the diagnosis and it is the curative treatment. Conservative treatment with an adhesive technique is a valid option in early cases. We report 20 cases of retronychia diagnosed in our department between 2010 and 2013.
© 2015 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2015        PMID: 26435476     DOI: 10.1111/jdv.13342

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  4 in total

1.  Occupational Retronychia: A Report of a Case in a UPS Employee.

Authors:  Nicole Nagrani; David E Castillo; Hind Al-Mohanna; Antonella Tosti
Journal:  Skin Appendage Disord       Date:  2019-01-03

Review 2.  Retronychia.

Authors:  Cristina Diniz Borges Figueira de Mello; Milena da Rocha E Souza; Leandro Fonseca Noriega; Nilton Di Chiacchio
Journal:  An Bras Dermatol       Date:  2018 Sep-Oct       Impact factor: 1.896

3.  Chronic Retronychia: Nonsurgical Treatment.

Authors:  Eckart Haneke; Ivana Manola; Iva Smiljan Benko; Marija Jozić; Ana-Marija Hursa
Journal:  Skin Appendage Disord       Date:  2022-01-21

Review 4.  Optimal diagnosis and management of common nail disorders.

Authors:  Debra K Lee; Shari R Lipner
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.